Observational study / 2017
High-dose individual vitamin B6 and B12 supplement use was linked to increased lung cancer risk in men, but not in women.
The VITAL cohort analyzed 77,118 participants aged 50 to 76 to evaluate 10-year average daily doses of supplemental B vitamins and incident lung cancer (808 cases). Supplemental vitamin B6, folate, and B12 were not associated with lung cancer risk in women. In men, individual supplement sources of B6 and B12 were linked to a 30% to 40% increased risk. Comparing the highest 10-year average dose categories to nonusers, lung cancer risk was higher for vitamin B6 (> 20 mg/d; HR 1.82, 95% CI 1.25 to 2.65) and B12 (> 55 µg/d; HR 1.98, 95% CI 1.32 to 2.97). This risk was even higher in male baseline smokers and was apparent across all histologic types except adenocarcinoma.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 77,118 participants aged 50 to 76 years from the VITAL cohort
- What was measured
- Incident primary invasive lung cancer
THE PAPER
Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort.
Brasky TM, White E, Chen CL. J Clin Oncol, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.